PRESS RELEASE published on 08/28/2023 at 13:30, 1 year 7 months ago NLS Pharmaceutics CEO Issues Letter to Shareholders
PRESS RELEASE published on 05/02/2023 at 14:45, 1 year 11 months ago NLS Pharmaceutics Receives Green Light from the U.S. FDA to Proceed with Phase 3 Clinical Program (AMAZE) for Quilience(R) (Mazindol ER) for the Treatment of Narcolepsy
PRESS RELEASE published on 03/27/2023 at 14:30, 2 years ago NLS Pharmaceutics Announces Open Label Extension Study Six-Month Data for Quilience(R) (Mazindol ER) in the Treatment of Narcolepsy Type 1 and Type 2
PRESS RELEASE published on 01/23/2023 at 14:30, 2 years 2 months ago NLS Pharmaceutics Announces New In-Vitro Data Reconfirming Quilience's(R) (Mazindol ER) Unique Dual Mechanism of Action Involving Significant Orexin-2 Receptor Activity
PRESS RELEASE published on 01/12/2023 at 14:30, 2 years 3 months ago NLS Pharmaceutics Announces an R&D Update Webcast to Review the Company's Growing Portfolio of Pre-Clinical Compounds
Published on 04/16/2025 at 02:25, 2 hours 47 minutes ago New High-Grade Assays Extend Tolmer Silver & Gold Zones
Published on 04/15/2025 at 23:40, 5 hours 32 minutes ago Electric Metals Announces Business Consulting Services Agreement With Terrella Capital
Published on 04/15/2025 at 23:30, 5 hours 42 minutes ago GameSquare Holdings Reports 2024 Full Year Results
Published on 04/15/2025 at 23:30, 5 hours 42 minutes ago AIML Announces Closing of Oversubscribed Private Placement
Published on 04/15/2025 at 23:00, 6 hours 12 minutes ago Cerrado Gold Announces Q1 2025 Production Results At Its Minera Don Nicolas Mine In Argentina
Published on 04/15/2025 at 23:54, 5 hours 18 minutes ago EQS-Adhoc: DATAGROUP enters into an Investment Agreement with and supports a public purchase offer of KKR at a price of EUR 54.00 per share in cash
Published on 04/15/2025 at 21:51, 7 hours 20 minutes ago EQS-Adhoc: Adtran Networks SE updates preliminary results for the financial year 2024
Published on 04/15/2025 at 18:53, 10 hours 19 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/15/2025 at 18:30, 10 hours 42 minutes ago GURIT REPORTS NET SALES OF CHF 85.2 MILLION IN THE FIRST QUARTER OF 2025; ANNUAL GENERAL MEETING APPROVES ALL AGENDA ITEMS
Published on 04/15/2025 at 18:00, 11 hours 12 minutes ago ALTHEORA: RESILIENCE DES RESULTATS ANNUELS 2024
Published on 04/15/2025 at 19:00, 10 hours 12 minutes ago Covivio Hotels - Descriptif du programme de rachat d’actions autorisé par l’Assemblée Générale Mixte des actionnaires du 15 avril 2025
Published on 04/15/2025 at 18:00, 11 hours 12 minutes ago NFL Biosciences annonce la mise à disposition de son rapport financier annuel 2024
Published on 04/15/2025 at 18:00, 11 hours 12 minutes ago Covivio Hotels - Revenus à fin mars 2025 : la croissance se poursuit
Published on 04/15/2025 at 18:00, 11 hours 12 minutes ago Covivio Hotels - Revenues at end-March 2025: continued growth
Published on 04/15/2025 at 17:45, 11 hours 27 minutes ago DAMARTEX / Droits de vote bruts et réels au 31 mars 2025
